Transcatheter tricuspid valve-in-valve in patents with transvalvular device leads

Mackram Eleid, Samuel J Asirvatham, Allison K. Cabalka, Donald J. Hagler, Peter Noseworthy, Nathaniel W. Taggart, Charanjit Rihal

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Objective: To describe the effects of percutaneously implanted valve-in-valve in the tricuspid position for patients with pre-existing transvalvular device leads. Methods: In this case series, we describe implantation of the Melody valve and SAPIEN XT valve within dysfunctional bioprosthetic tricuspid valves in three patients with transvalvular device leads. Results: In all cases, the valve was successfully deployed and device lead function remained unchanged. In 1/3 cases with 6-month follow-up, device lead parameters remain unchanged and transcatheter valve-in-valve function remains satisfactory. Conclusions: Transcatheter tricuspid valve-in-valve is feasible in patients with pre-existing transvalvular devices leads. Further study is required to determine the long-term clinical implications of this treatment approach.

Original languageEnglish (US)
JournalCatheterization and Cardiovascular Interventions
StateAccepted/In press - 2015


  • Percutaneous valve therapy
  • Structural heart disease intervention
  • Transcatheter valve implantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Transcatheter tricuspid valve-in-valve in patents with transvalvular device leads'. Together they form a unique fingerprint.

Cite this